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Purpose of the study: Cognitive stimulation therapy (CST) is a widely used, evidence-based 
intervention for people with dementia (PwD). Although designed as a 14 session, twice weekly 
intervention, many services in the UK deliver CST once a week for 14 weeks. However, this 
method of delivery has yet to be evaluated. In addition, CST does not include any formal carer 
training. This study aimed to evaluate the effectiveness of once weekly CST and determine any 
additional impact when enhanced with a carer training program.
Design and methods: A single blind, randomized controlled trial was conducted. Sixty eight 
PwD and their carers were recruited through three community Memory Assessment Services. 
PwD and their carers were randomized to one of three conditions: CST plus carer training, CST 
only, or a wait list control. PwD were administered standardized measures of cognition, quality 
of life, and quality of relationship with carer at baseline and the 15 week follow-up.
Results: There were no baseline differences across the three groups. At follow-up, there were 
no significant differences between PwD in the three groups on any outcomes. 
Implications: Weekly CST with or without carer training may not be an effective form of 
delivery. Several possible explanations for the outcomes are proposed. Weekly CST may not 
offer the necessary “dose” required to combat decline, and equally the carer training may have 
been too brief to have made a difference. Services currently offering weekly CST should collect 
routine outcome data to support its use and provide practice-based evidence.
Keywords: Alzheimer’s disease, cognition, intervention, caregiver
Introduction
Dementia is a progressive mental health disorder characterized by pervasive impairment 
of mental function. Currently in the UK there are an estimated 800,000 people living 
with dementia, and it is predicted that by 2021 this figure will rise to over one million.1 
The need for effective and accessible treatments is paramount. Cognitive stimulation 
is a non-pharmacological treatment with consistent evidence of positive outcomes 
for people with dementia (PwD) with respect to their cognitive functioning, social 
interaction, communication and quality of life.2
One example of cognitive stimulation is Cognitive Stimulation Therapy (CST), a 
brief, evidence-based, 14 session, twice-weekly group therapy for people with mild to 
moderate dementia. CST leads to improved cognition and quality of life when com-
pared to treatment as usual3 and has positive effects on the behavior of PwD.2 CST is 
also cost effective,4 shows comparable benefits to acetylcholinesterase inhibitor drugs2 
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and is effective regardless of whether participants are also 
taking medication for their dementia.5
Dementia can have significant negative impacts on 
caregivers including poorer physical and mental health, 
quality of life, self-efficacy and social support.6 These 
negative carer outcomes are also associated with poorer 
outcomes for the PwD, including decreased quality of 
life and early admission to care homes.6 Involving car-
ers in cognitive stimulation interventions for the person 
they care for can have positive benefits for both carers 
and the PwD.7,8 These studies found that involving carers 
in cognitive stimulation resulted in improved memory, 
problem solving and verbal fluency for PwD, whilst carers 
experienced enhanced communication and interaction with 
the person they care for, as well as maintenance of their 
quality of life and psychological well-being. To date, for-
mal carer involvement in CST has not, to our knowledge, 
been evaluated. At present, CST does not include any 
formal carer involvement. However, involving carers in 
CST may allow PwD to receive a higher “dose” of CST if 
carers apply its principles and use CST activities between 
sessions. This may produce additional benefits for PwD 
in line with previous research.
Limited Phase IV implementation work9 has been con-
ducted to evaluate the effectiveness of CST in clinical prac-
tice. Although CST was designed and evaluated as a 7 week, 
14 session program, in practice many National Health Service 
services deliver the program once a week over 14 weeks, due 
to time constraints and resource limitations. However, this 
format is yet to be evaluated. 
Consequently, the aims of this study were to establish 
the effectiveness of CST when delivered once a week for 
14 weeks, and to evaluate whether additional carer training 
led to any benefits above and beyond weekly CST. 
Design and methods
Design
A single blind, randomized control design was used with 
three independent conditions. In treatment condition one 
(N=21), PwD received 14 sessions of weekly CST and their 
carers received CST training (CST plus carer training). In 
treatment condition two (N=24), PwD received 14 sessions of 
weekly CST (CST only). The control condition (N=23) was 
a waiting list group (no CST, no carer training). On comple-
tion of the study, PwD in the control group were offered CST 
and carers in the CST only and control groups were offered 
session one of the carer training program. Assessors were 
blinded to treatment allocation. In an attempt to facilitate 
this, participants were reminded not to reveal the group they 
were in before each assessment. 
randomization
Participants were randomized using the block method10 to 
achieve equal group sizes and using Random Allocation 
Software version 1.11 Randomization was conducted sepa-
rately for each site (to minimize travel time), by the clinician 
who would be running the CST groups, but not undertaking 
assessments. 
setting
Data collection took place across three sites within South 
Essex Partnership Trust in Bedfordshire, UK. All CST groups 
and carer training sessions were conducted in community set-
tings, with transport available for those who needed it. Care 
for the person with dementia was provided when needed, to 
facilitate carers’ attendance. 
Participants 
Inclusion criteria
Eligibility criteria for PwD were adapted from previous 
research.3 Subjects were eligible for participation if they: 
1. Met the Diagnostic and Statistical Manual of Mental Disor-
ders, Fourth Edition criteria for dementia of any type.12
2. Scored 18 to 30 on the Mini-Mental State Examination 
(MMSE)13 indicating mild to moderate dementia. 
3. Could speak English and had some ability to commu-
nicate and understand communication – a score of 1 
or 0 on questions 12 and 13 of the Clifton Assessment 
Procedures for the Elderly – Behaviour Rating Scale 
(CAPE–BRS).14
4. Lived in the community (ie, not in a residential setting).
5. Were able to see and hear well enough to participate in the 
group and make use of most of the material in the program.
6. Could engage in group activity for at least 45 minutes.
7. Did not have major physical illness or disability which 
could affect participation.
8. Did not have a diagnosis of a learning disability.
9. Had a carer who was willing to take part in the study (and 
met inclusion criteria – see carer criteria to follow).
The research team developed a set of inclusion criteria for 
carers to ensure that they could participate fully in the research. 
Carers were considered eligible for participation if they:
1. Had a minimum of three contacts per week with the 
person they cared for, and were able to continue this for 
the period of the research study.
2. Were aged 18 years or above.
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3. Could speak English.
4. Did not have major physical illness or disability that could 
affect participation.
All PwD who had a) been through one of the South Essex 
Partnership Trust’s Memory Assessment Clinics during the 
previous 2 years, or who were on the waiting list for CST; 
b) met the inclusion criteria; and c) had a carer who met 
the inclusion criteria, were invited to take part in the study, 
along with their carer.
Power analysis 
As no previous research was found examining the effect of 
once weekly CST or carer involvement, it was not possible 
to calculate an a priori sample size. However, using G*Power 
3.115 it was determined that a sample size of 144 participants 
(72 PwD and their carers; dyads), with power set at 0.80 and 
5% significance would be adequate to detect an effect size 
of 0.34 or above.
Procedure 
recruitment
Dyads who met inclusion criteria were contacted to discuss 
the study. Separate information sheets for PwD and carers 
were sent to those who expressed an interest in participat-
ing. For those who agreed to participate, written informed 
consent was obtained, in accordance with the provisions of 
the Mental Capacity Act.16
Intervention: CsT
The study followed the standardized CST manual.17 Groups 
were held weekly for 14 weeks, with individually themed 
sessions lasting approximately 45 minutes. A reality orien-
tation board was used and sessions opened with the group 
song, followed by a warm up exercise and discussion of 
a recent news article. The main activity then followed, 
based on that week’s theme. Sessions were designed to be 
as inclusive as possible and activities were tailored to the 
groups’ abilities. 
Intervention: carer CsT training program
This was adapted from the current CST training program 
and training manual.18 An initial version of session one 
was field-tested prior to the start of the research with a 
group of nine carers of PwD who had recently attended 
a CST group. Adaptations were made based on feedback 
received. Carers were asked to attend two sessions, with an 
optional workshop offered between the sessions. Session 
one lasted 3 hours and was delivered to coincide with 
the first CST group. Carers were given an overview of 
dementia and of the development of/rationale for CST. The 
CST program was outlined and details of the individual 
sessions were presented. The 18 guiding principles of CST 
were described and ways of engaging the person at home 
according to these principles were suggested. Carers were 
given a workbook outlining activities that related to each 
theme undertaken in the CST program, which they could 
try with the PwD between CST sessions. The workbook 
contained a diary to record and rate the success of activities 
tried at home. 
Session two was delivered during the final week of the 
CST program and lasted approximately 1 hour. The focus 
was on maintaining the skills acquired into the future. An 
overview of CST sessions and underlying principles was 
presented and time was given for addressing concerns and 
sharing ideas. An optional 1 hour question and answer ses-
sion was offered at week 7.
The aim of the program was not to train carers to deliver 
CST, but to provide them with training about the nature and 
rationale of CST, introduce essential skills around interacting 
with the person they care for, and on implementing activities 
at home using the guiding principles of CST. The objective 
was to enhance the interactions between the carer and the 
person they care for in their home environment in such a way 
that carers felt empowered and could support the experience 
of the CST group for the person cared for.
Assessments
All participants were assessed at baseline (the 2 week 
period before the intervention) and at follow-up (the 
2 week period following the intervention). Carers were 
asked to provide demographic details for themselves and 
the PwD.
Outcome measures
Measures of cognition and quality of life that had showed 
sensitivity to change in previous CST research were selected.3 
In addition, the quality of the PwD-carer relationship was 
assessed. This has not been previously assessed in CST trials, 
as they have not included carer input.
Cognition
Two measures were used – the widely used MMSE,13 a 
brief 30-item test; and the Alzheimer’s Disease Assessment 
Scale–Cognition (ADAS–Cog),19 a more comprehensive and 
extensive measure of cognitive function than the MMSE, 
with good reliability and validity in dementia. 
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Quality of life
Quality of life was assessed using the Quality of Life–
Alzheimer’s Disease scale (QoL-AD)20 a brief 13-item 
questionnaire delivered in interview format. The QoL-AD 
has good internal consistency, validity, and reliability.21
Quality of the caregiving relationship 
The quality of the caregiving relationship was assessed using 
the Quality of Caregiver and Patient Relationship (QCPR).22 
This scale is a 14-item measure assessing relationship qual-
ity. Good reliability and validity have been demonstrated.22
ethics
Ethical approval for this study was granted by London 
South East National Research Ethics Service (NRES) 
Committee.
Data analysis
SPSS version 17 was used to analyze data. Intention-to-
treat analysis was applied using the last observation carried 
forward method for data missing at follow-up. One-way 
analysis of variance and χ 2 tests were used to check for 
differences in demographics between participants in the 
three conditions at baseline. Outcomes were analyzed using 
mixed-method analysis of covariance to allow for variability 
in baseline characteristics (covariates) to be controlled. The 
age and sex of the PwD were entered as covariates. 
Results
recruitment and attrition
One hundred and sixty six dyads were identified as suitable 
for inclusion. Of these, 122 dyads consented to receive infor-
mation packs, and of these 72 dyads consented to participate 
and were randomized into one of the three treatment condi-
tions. Four dyads dropped out before the first assessment, 
therefore no data was available for these participants, and 
they were not included in the final analyses. Nine dyads 
dropped out between the first assessment and follow-up. 
Figure 1 displays details of the flow of participants through 
the research. There were no significant differences in the 
proportion of completers and non-completers across the 
three conditions, χ 2(2)=1.042, P=0.594, and groups were 
well matched in baseline characteristics (age, sex, diagnosis, 
carer age, carer sex, scores on outcome measures).
Participant characteristics
A description of the characteristics of PwD across the three 
conditions can be found in Table 1.
Carer attendance at the training program
Of the 21 carers in the CST plus carer training condition, 
14 attended all sessions. Two attended sessions one and two, 
but not the optional workshop; four attended session one 
only; and one did not attend any sessions. Although carers 
were asked to record all CST activity they used at home, the 
majority of carers did not, meaning very little quantitative 
data about level of use of CST activities or principles were 
available. 
Analysis of outcomes
There were no significant baseline differences across the three 
conditions on any of the outcome measures: MMSE (F[2, 
67]=0.16, P=0.85); ADAS–Cog (F[2, 65]=0.05, P=0.96); 
QoL-AD (F[2, 67]=0.69, P=0.51); QCPR (F[2, 66]=0.22, 
P=0.81). Mean scores at baseline and follow-up for each 
outcome measure for each condition are displayed in Table 2, 
which also displays between-group effects and effect sizes 
from the analysis of covariance.
There were no changes in cognition as assessed by 
the MMSE over time (F[1, 63]=0.81, P=0.37 [η
p
2=0.01]) 
and no significant differences between the three groups at 
follow-up (F[1, 63]=0.84, P=0.92 [η
p
2=0.003]). Although 
there was a significant decline in cognition between base-
line and follow-up across the whole group as assessed by 
the ADAS–Cog (F[1, 61]=4.38, P=0.04) this effect was 
very small (η
p
2=0.07), and there were no between-group 
differences on this measure at follow-up (F[1, 61]=0.02, 
P=0.98 [η
p
2=0.001]). There were no between-group differ-
ences on any of the 12 subscales of the ADAS–Cog. There 
were no changes in QoL-AD over time (F[1, 61]=0.003, 
P=0.96 [η
p
2=0.0001]), and no differences between the three 
groups at follow-up (F[1, 63]=0.82, P=0.44 [η
p
2=0.03]). 
Similarly, there were no changes in the QCPR over time 
(F[1, 62]=1.68, P=0.20 [η
p
2=0.03]), and no between-
group differences at follow-up (F[1, 62]=0.97, P=0.39 
[η
p
2=0.03]). 
Discussion
No improvements in cognition, quality of life or the 
quality of the caregiving relationship were observed in 
PwD receiving once weekly CST, with or without carer 
training. These results suggest that delivering manualized 
CST weekly may not be enough to make a difference, and 
that this cannot be enhanced through provision of carer 
training. Twice weekly CST may be necessary to provide 
the required “dose” to combat the natural deterioration 
in dementia and have a positive effect. However, it is 
Clinical Interventions in Aging 2014:9 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2147
Weekly CsT and carer training
important to consider several other possible explanations 
of the results observed.
Firstly, cognitive functioning as assessed by the MMSE 
and the ADAS–Cog was higher in the present study than 
in previous trials.2,3 It may be that CST is less effective for 
this higher functioning group or that these measures are less 
sensitive to change as they approach ceiling effects. This 
latter conclusion is supported by one study23 which included 
participants with high baseline MMSE scores. Following 
CST, they observed no changes in cognition as assessed 
Figure 1 Participant flow through the study.
Abbreviations: CsT, cognitive stimulation therapy; PwD, people with dementia.
Dyads referred and met
inclusion criteria N=166
Dyads received participant
information sheets N=122
Randomization N=72
CST plus carer
training N=24 CST N=24 Control N=24
Withdrew N=3
1 PwD died
1 PwD became unwell
1 change in family
circumstances
Withdrew N=0
Withdrew N=1
1 change in family
circumstances
Completed first
assessment N=21
Completed first
assessment N=24
Completed first
assessment N=23
Withdrew N=4
1 PwD became
unwell
3 carers withdrew
Withdrew N=3
2 PwD withdrew from
CST
1 carer withdrew
Withdrew N=2
1 PwD died
1 change in family
circumstances
Completed second
assessment N=17
Completed second
assessment N=21
Completed second
assessment N=21
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by the MMSE, yet found significant changes in other more 
sensitive neuropsychological tests.
Secondly, outcomes were selected based on those which 
had shown improvements in previous research.3 However, it 
is possible that higher functioning PwD benefit in a different 
way from CST and there could have been positive outcomes 
in other unmeasured domains, such as wider social benefits 
or self-esteem. It may also be that once weekly CST reduces 
health and social care costs, eg, through providing an ongoing 
support network, and reducing other use of services such as 
general practitioner (GP) visits and hospital admissions.
The lack of effect of carer training may be due to failure 
to achieve its aim of providing a higher “dose” of CST. The 
maximum number of hours training received was five, with 
many people receiving fewer. This may simply not have been 
enough to achieve changes in interactions or activities under-
taken at home. Furthermore, almost no quantitative data were 
available to show the extent to which carers used any of the 
Table 1 Baseline characteristics of participants with dementia
CST plus carer training CST Control
Age in years, mean (sd) 75.4 (5.56) 76.8 (6.62) 77.8 (7.47)
sex
Male (%)
Female (%)
11 (52.4)
10 (47.6)
15 (62.5)
9 (37.5)
10 (43.5)
13 (56.5)
ethnicity
White British (%)
White Irish (%)
White other (%)
Black Caribbean (%)
Indian (%)
17 (81.0)
0 (0)
2 (9.5)
2 (9.5)
0 (0)
23 (95.8)
0 (0)
0 (0)
0 (0)
1 (4.2)
19 (82.6)
2 (8.7)
0 (0)
2 (8.7)
0 (0)
living situation
Private accommodation (%)
sheltered housing (%)
supported living (%)
20 (95.2)
0 (0)
1 (4.8)
20 (83.3)
1 (4.2)
3 (12.5)
23 (100)
0 (0)
0 (0)
Dementia diagnosis sub-type
Alzheimer’s disease (early onset) (%)
Alzheimer’s disease (late onset) (%)
Alzheimer’s disease (atypical/mixed) (%)
Vascular dementia (%)
subcortical vascular dementia (%)
Dementia in Parkinson’s disease (%)
Unspecified dementia (%)
0 (0)
15 (71.4)
1 (4.8)
0 (0)
2 (9.5)
0 (0)
3 (14.3)
0 (0)
11 (47.8)
2 (8.7)
3 (13.0)
1 (4.3)
4 (17.4)
2 (8.7)
1 (4.3)
10 (43.5)
6 (26.1)
1 (4.3)
2 (8.7)
1 (4.3)
2 (8.7)
Dementia severity
Mild (%)
Moderate (%)
15 (71.4)
6 (28.6)
18 (75.0)
6 (25.0)
17 (73.9)
6 (26.1)
living with carer
Yes (%)
no (%)
18 (85.7)
3 (14.3)
19 (79.2)
5 (20.8)
19 (82.6)
4 (17.4)
relationship to carer
spouse (%)
Partner (%)
Mother/father (%)
Mother/father-in-law (%)
Aunt/uncle (%)
17 (81.0)
0 (0)
4 (19.0)
0 (0)
0 (0)
17 (70.8)
0 (0)
5 (20.8)
2 (8.3)
0 (0)
17 (73.9)
1 (4.3)
4 (17.4)
0 (0)
1 (4.3)
Age of carer, mean (sd) 68.81 (10.39) 67.13 (11.26) 70.43 (11.12)
number of medications, mean (sd) 5.19 (4.14) 3.88 (2.62) 5.70 (4.16)
Dementia medication
Yes (%)
no (%)
10 (47.6)
11 (52.4)
16 (66.7)
8 (33.3)
13 (56.5)
10 (43.5)
Attended previous dementia intervention
Yes (%)
no (%)
1 (4.8)
20 (95.2)
3 (12.5)
21 (87.5)
3 (13.0)
20 (87.0)
number of CsT sessions attended,  
mean (sd)
10.95 (3.64) 10.50 (4.53) n/A
Abbreviations: CsT, cognitive stimulation therapy; sd, standard deviation; n/A, not applicable.
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recommended activities, or adapted their interactions accord-
ing to the CST principle. It is therefore possible that carers were 
not using the CST at home, meaning that PwD in the CST plus 
carer training group did not receive a higher “dose”’ of the 
intervention than those in the CST group as planned.
limitations
Attempts were made to ensure that assessors were blind to 
participants’ group allocation. However, no formal measure 
of the integrity of the blinding process was included. There-
fore, it was not possible to determine the extent of observer 
bias. Secondly, no monitoring of treatment fidelity was 
undertaken, hence the extent to which CST sessions were 
implemented as planned is unknown. Adherence checks 
would have increased confidence in treatment  fidelity. 
Finally, although the study was powered to detect large 
effect sizes, the relatively small sample size meant that it 
was underpowered to detect smaller effects. A larger sample 
size would be preferable in order to draw conclusions with 
acceptable statistical significance.
Implications
The current study does not provide support for weekly 
CST and the addition of a carer training program. Services 
should consider carefully whether to run CST groups 
once or twice weekly, balancing the evidence-based and 
the National Institute for Health and Care Excellence 
(NICE) guidelines alongside practical issues, such as time, 
resources, and participant availability. Where a once weekly 
format is used, service-level monitoring of outcomes is 
essential to ensure that those who participate are benefit-
ing, and to provide service-level data that can be used to 
further explore the effectiveness, or not, of weekly CST. 
Any benefit for PwD of including carer training should 
similarly be monitored and assessed using relevant outcome 
measures.
It is recommended that the current study be replicated using 
a larger sample to enhance power, and use a wider range of 
outcome measures to capture possible benefits missed, eg, 
mood, communication and behavior, and longer term costs. 
Including a cost-effective analysis in future research would 
facilitate a comparison with other services to determine 
whether CST offers a lower cost alternative to such services.
Further development of the carer training program will 
also be of benefit. We developed the carer training program 
to be a brief, low intensity intervention, however a more 
intensive program may be necessary to achieve the desired 
effects. Furthermore, future studies should ensure carers 
adequately use CST activities and principles at home. 
Conclusion
The current project does not provide evidence that weekly 
CST is effective, or that enhancing CST with carer training 
offers additional benefits to PwD. While service provid-
ers should 1) exercise caution if offering CST in a weekly 
program; and 2) consider changing to offer a twice weekly 
program, continued collection of outcome data will allow 
for on-going monitoring of the progress of participants to 
establish whether self-reported benefits from participants of 
weekly CST are being achieved. 
Disclosure
Dr Helen Donovan and Nicola Jacobi are both employees 
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Stott offer CST training on a commercial basis. The authors 
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Table 2 Mean scores at baseline and follow-up for each outcome measure
Baseline Follow-up ANCOVA 
between 
group 
difference 
Effect 
size 
(ηp2)
CST plus 
carer 
training
CST Control CST plus 
carer 
training
CST Control
Mini-Mental state examination 22.33 
(3.54)
22.71 
(3.76)
22.91 
(3.01)
22.19 
(4.48)
22.38 
(4.75)
22.13 
(3.40)
F=0.84, 
P=0.92
0.003
Alzheimer’s Disease Assessment 
scale–Cognition
18.35 
(7.1)
18.13 
(8.24)
17.68 
(6.51)
20.10
(7.6)
19.04
(8.13)
20.09
(7.2)
F=0.02, 
P=0.98
0.001
Quality of life–Alzheimer’s 
Disease scale
36.43 
(6.06)
36.42 
(5.44)
34.78 
(5.43)
36.45
(5.6)
35.65
(5.83)
35.32
(5.51)
F=0.82, 
P=0.44
0.03
scale for the Quality of the 
Current relationship in Caregiving
57.38 
(6.49)
57.09 
(6.91)
56.13 
(6.53)
57.90
(6.61)
55.65
(6.83)
56.41
(6.53)
F=0.97, 
P=0.39
0.03
Note: standard deviations shown in brackets.
Abbreviations: AnCOVA, analysis of covariance; CsT, cognitive stimulation therapy.
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